# Zhi Pet Pharmaceutical

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/zhi-pet-pharmaceutical

- Industry: Pharmaceuticals
- Headquarters: Beijing, China
- Latest round: Angel (Jul 6, 2023)
- Investors on record: 2

## About

Founded in 2022 and based in Beijing, China, Zhi Pet Pharmaceutical is an animal drug company that focuses on using AIDS to assist animal drug design. In July 2023, the company raised angel funding led by new investor Legend Star. Other new investor MiraclePlus China also participated in the round. Wenjuan Wei, the founder of the company, worked in the Arkansas Children's Hospital and North Carolina State University in the United States for 2 years in pharmaceutical clinical statistics and served as the CEO of Shenzhen Zhiyao Information Technology Co., Ltd.


The company's main product is ZC001, an anti-coronavirus drug for animals. It has two platforms for animal genome-wide CRISPR screening and AI-assisted design of large and small molecules. The CRISPR platform enables efficient discovery and validation of new targets.

## Funding rounds

- Angel, Jul 6, 2023 — Legend Star, MiraclePlus

## Investors

- Legend Star (https://capitalatlas.ai/funds/legend-star) — Angel
- MiraclePlus (https://capitalatlas.ai/funds/miracleplus) — Angel